Reentry tools to help Veterans transition successfully after prison

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The work is conducted in three phases beginning with qualitative interviews of veterans released within the past 36 months to document transition experiences, stigma, and behaviors that interfered with success. Phase 2a uses those findings to design a tailored transition program and Phase 2b creates assessment tools to guide the program. Phase 3 is a pilot two-group randomized crossover comparison of the new program versus usual VA care to gather feasibility, acceptability, and preliminary outcome data. The interventions include the START-VETS reentry program compared with treatment as usual delivered at the Dallas VA Medical Center.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Veteran with mental illness and/or substance use disorder released from prison within the past 36 months

Exclusion Criteria:

* Psychosis or cognitive impairment precluding active participation

Where it's running

• VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
  Dallas, Texas, United States Recruiting

Study contacts

• Principal investigator: James P. LePage, PhD — VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
• Study coordinator: April Crawford, MS
• Email: april.crawford@va.gov
• Phone: (214) 857-2571

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Honest, Open, Proud for justice-involved veterans

  This trial tests a peer-delivered stigma-reduction program for veterans with co-occurring mental health or substance use disorders who are involved with the justice system, to see if different delivery intensities help more veterans engage in care.

  Recruiting VA Office of Research and Development · Bedford, Massachusetts · NCT07742722

• How people disclose suicidal thoughts and get support in rural eastern Uganda

  This study tests how disclosure of suicidal thoughts or severe distress affects social support or harm, and who should be involved in future help.

  Recruiting Yale University · Mpunde, Buyende District · NCT07730307

• Olfactory function and decision-making in people with HIV and/or substance use

  This study tests how the sense of smell relates to decision-making in adults with HIV, substance use, both, or neither.

  Recruiting National Institutes of Health Clinical Center (CC) · Baltimore, Maryland · NCT07637669

• HB-1 for PTSD: testing safety and efficacy vs placebo in adults 18-65

  This study tests whether HB-1 helps reduce PTSD symptoms in adults aged 18–65 compared with a placebo.

  Recruiting at 16 sites Phase 2 HB BioTech, LLC · Deakin, Australian Capital Territory and 15 other locations · NCT07499440

• Psychosocial factors linked to outcomes in people with dual diagnosis in a hospital

  This study tests how psychosocial protective factors relate to clinical and functional outcomes in adults hospitalized with both a mental health disorder and substance use disorder.

  Recruiting Hospital Virgen del Puerto · Plasencia, Caceres · NCT07443033

• Testing the French PHQ-4 and PC-PTSD-5 short mental health screens

  This project will test whether the French PHQ-4 and PC‑PTSD‑5 questionnaires work well to quickly screen for anxiety/depression and PTSD in French-speaking adults seen in hospital or outpatient care.

  Recruiting Assistance Publique - Hôpitaux de Paris · Bobigny · NCT07396623

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.